Myomo Q4 2025 Earnings Call Transcript

robot
Abstract generation in progress

Myomo reported strong Q4 2025 results with a record $11.4 million in revenue, contributing to a full-year revenue of $40.9 million, a 26% increase over 2024. The company saw a record 241 MyoPro orders and expanded recurring revenue sources, now accounting for 42% of total revenue. Despite challenges with Medicare Advantage denials and increased operating expenses, Myomo provided 2026 revenue guidance of $43-$46 million, aiming to halve cash burn and improve gross margins through initiatives like the Myomo mobile app and strategic channel focus.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin